Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus

被引：119

作者：

Imai, J

Ieiri, I

Mamiya, K

Miyahara, S

Furuumi, H

Nanba, E

Yamane, M

Fukumaki, Y

Ninomiya, H

Tashiro, N

Otsubo, K

Higuchi, S

机构：

[1] Tottori Univ, Fac Med, Dept Hosp Pharm, Yonago, Tottori 6838504, Japan

[2] Tottori Univ, Ctr Gene Res, Yonago, Tottori 6838504, Japan

[3] Kyushu Univ, Inst Genet Informat, Higashi Ku, Fukuoka, Japan

[4] Kyushu Univ, Fac Med, Div Pharmaceut Sci, Higashi Ku, Fukuoka, Japan

[5] Kyushu Univ, Fac Med, Dept Neuropsychiat, Higashi Ku, Fukuoka, Japan

来源：

PHARMACOGENETICS | 2000年 / 10卷 / 01期

关键词：

CYP2C9; genetic analysis; polymorphism; new mutations; Japanese;

D O I：

10.1097/00008571-200002000-00011

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：85 / 89

页数：5

共 13 条

[1] Allelic and functional variability of cytochrome P4502C9 [J].

Bhasker, CR ;

Miners, JO ;

Coulter, S ;

Birkett, DJ .

PHARMACOGENETICS, 1997, 7 (01) :51-58

[2] GENE STRUCTURE AND UPSTREAM REGULATORY REGIONS OF HUMAN CYP2C9 AND CYP2C18 [J].

DEMORAIS, SMF ;

SCHWEIKL, H ;

BLAISDELL, J ;

GOLDSTEIN, JA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) :194-201

[3] Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy [J].

Furuya, H ;

FernandezSalguero, P ;

Gregory, W ;

Taber, H ;

Steward, A ;

Gonzalez, FJ ;

Idle, JR .

PHARMACOGENETICS, 1995, 5 (06) :389-392

[4]

GOTOH O, 1992, J BIOL CHEM, V267, P83

[5] Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population [J].

Kimura, M ;

Ieiri, I ;

Mamiya, K ;

Urae, F ;

Higuchi, S .

THERAPEUTIC DRUG MONITORING, 1998, 20 (03) :243-247

[6] The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: Studies in stereoselective hydroxylation and population pharmacokinetics [J].

Mamiya, K ;

Ieiri, I ;

Shimamoto, J ;

Yukawa, E ;

Imai, J ;

Ninomiya, H ;

Yamada, H ;

Otsubo, K ;

Higuchi, S ;

Tashiro, N .

EPILEPSIA, 1998, 39 (12) :1317-1323

[7] Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy [J].

Odani, A ;

Hashimoto, Y ;

Otsuki, Y ;

Uwai, Y ;

Hattori, H ;

Furusho, K ;

Inui, K .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :287-292

[8] CLONING AND EXPRESSION OF COMPLEMENTARY DNAS FOR MULTIPLE MEMBERS OF THE HUMAN CYTOCHROME-P450IIC SUBFAMILY [J].

ROMKES, M ;

FALETTO, MB ;

BLAISDELL, JA ;

RAUCY, JL ;

GOLDSTEIN, JA .

BIOCHEMISTRY, 1991, 30 (13) :3247-3255

[9] Genetic analysis of the human cytochrome P450 CYP2C9 locus [J].

Stubbins, MJ ;

Harries, LW ;

Smith, G ;

Tarbit, MH ;

Wolf, CR .

PHARMACOGENETICS, 1996, 6 (05) :429-439

[10] The role of the CYP2C9-Leu(359) allelic variant in the tolbutamide polymorphism [J].

SullivanKlose, TH ;

Ghanayem, BI ;

Bell, DA ;

Zhang, ZY ;

Kaminsky, LS ;

Shenfield, GM ;

Miners, JO ;

Birkett, DJ ;

Goldstein, JA .

PHARMACOGENETICS, 1996, 6 (04) :341-349

← 1 2 →